348 related articles for article (PubMed ID: 11238922)
21. Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor.
Castaño E; Kleyner Y; Dynlacht BD
Mol Cell Biol; 1998 Sep; 18(9):5380-91. PubMed ID: 9710622
[TBL] [Abstract][Full Text] [Related]
22. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts.
Afshari CA; Nichols MA; Xiong Y; Mudryj M
Cell Growth Differ; 1996 Aug; 7(8):979-88. PubMed ID: 8853893
[TBL] [Abstract][Full Text] [Related]
23. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation and activation of B-Myb by cyclin A-Cdk2.
Ziebold U; Bartsch O; Marais R; Ferrari S; Klempnauer KH
Curr Biol; 1997 Apr; 7(4):253-60. PubMed ID: 9094315
[TBL] [Abstract][Full Text] [Related]
25. Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1).
Hengst L; Göpfert U; Lashuel HA; Reed SI
Genes Dev; 1998 Dec; 12(24):3882-8. PubMed ID: 9869641
[TBL] [Abstract][Full Text] [Related]
26. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.
Schulman BA; Lindstrom DL; Harlow E
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10453-8. PubMed ID: 9724724
[TBL] [Abstract][Full Text] [Related]
27. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
[TBL] [Abstract][Full Text] [Related]
28. Function of hybrid human-yeast cyclin-dependent kinases in Saccharomyces cerevisiae.
Bitter GA
Mol Gen Genet; 1998 Oct; 260(1):120-30. PubMed ID: 9829836
[TBL] [Abstract][Full Text] [Related]
29. Differences in substrate specificity between Cdk2-cyclin A and Cdk2-cyclin E in vitro.
Higashi H; Suzuki-Takahashi I; Taya Y; Segawa K; Nishimura S; Kitagawa M
Biochem Biophys Res Commun; 1995 Nov; 216(2):520-5. PubMed ID: 7488142
[TBL] [Abstract][Full Text] [Related]
30. Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry.
Zhao J; Dynlacht B; Imai T; Hori T; Harlow E
Genes Dev; 1998 Feb; 12(4):456-61. PubMed ID: 9472014
[TBL] [Abstract][Full Text] [Related]
31. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
Sarcevic B; Lilischkis R; Sutherland RL
J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
[TBL] [Abstract][Full Text] [Related]
32. The protein SET regulates the inhibitory effect of p21(Cip1) on cyclin E-cyclin-dependent kinase 2 activity.
Estanyol JM; Jaumot M; Casanovas O; Rodriguez-Vilarrupla A; Agell N; Bachs O
J Biol Chem; 1999 Nov; 274(46):33161-5. PubMed ID: 10551888
[TBL] [Abstract][Full Text] [Related]
33. BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site.
Ruffner H; Jiang W; Craig AG; Hunter T; Verma IM
Mol Cell Biol; 1999 Jul; 19(7):4843-54. PubMed ID: 10373534
[TBL] [Abstract][Full Text] [Related]
34. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors.
Adams PD; Sellers WR; Sharma SK; Wu AD; Nalin CM; Kaelin WG
Mol Cell Biol; 1996 Dec; 16(12):6623-33. PubMed ID: 8943316
[TBL] [Abstract][Full Text] [Related]
35. Dependence of cyclin E-CDK2 kinase activity on cell anchorage.
Fang F; Orend G; Watanabe N; Hunter T; Ruoslahti E
Science; 1996 Jan; 271(5248):499-502. PubMed ID: 8560263
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase.
Koepp DM; Schaefer LK; Ye X; Keyomarsi K; Chu C; Harper JW; Elledge SJ
Science; 2001 Oct; 294(5540):173-7. PubMed ID: 11533444
[TBL] [Abstract][Full Text] [Related]
37. The amino terminus of Cdk2 binds p21.
Moskowitz NK; Borao FJ; Dardashti O; Cohen HD; Germino FJ
Oncol Res; 1996; 8(9):343-52. PubMed ID: 8979268
[TBL] [Abstract][Full Text] [Related]
38. Regulation of the ubiquitin-conjugating enzyme hHR6A by CDK-mediated phosphorylation.
Sarcevic B; Mawson A; Baker RT; Sutherland RL
EMBO J; 2002 Apr; 21(8):2009-18. PubMed ID: 11953320
[TBL] [Abstract][Full Text] [Related]
39. Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors.
Hara E; Hall M; Peters G
EMBO J; 1997 Jan; 16(2):332-42. PubMed ID: 9029153
[TBL] [Abstract][Full Text] [Related]
40. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E.
Won KA; Reed SI
EMBO J; 1996 Aug; 15(16):4182-93. PubMed ID: 8861947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
